2018
DOI: 10.1007/978-3-319-90107-7_6
|View full text |Cite
|
Sign up to set email alerts
|

Future Therapeutics in Psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0
2

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 37 publications
0
1
0
2
Order By: Relevance
“…Oligodeoxynucleotides (ODNs) were first designed for direct binding and for antagonizing endosomal TLRs as an alternate strategy to treat SLE, which despite showing initial success the therapy, failed to garner support due to several reports of adverse effects like thrombocytopenia and neutropenia. Although greater promise was shown by ODNs, like immunomodulatory oligonucleotides (IMO)-8400 in psoriasis that target TLR7, TLR8, and TLR9 to reduce the expression of IL-17 signaling associated genes[ 120 , 121 ]. A phase 2a clinical trial, sponsored by Idera Pharmaceuticals, involving use of IMO-8400 for the treatment of plaque psoriasis exhibited reduced psoriasis severity with good tolerance in the recruited subjects (NCT01899729)[ 122 ].…”
Section: Targeting Nucleic Acid Sensing Pathways: Therapeutic Strategiesmentioning
confidence: 99%
“…Oligodeoxynucleotides (ODNs) were first designed for direct binding and for antagonizing endosomal TLRs as an alternate strategy to treat SLE, which despite showing initial success the therapy, failed to garner support due to several reports of adverse effects like thrombocytopenia and neutropenia. Although greater promise was shown by ODNs, like immunomodulatory oligonucleotides (IMO)-8400 in psoriasis that target TLR7, TLR8, and TLR9 to reduce the expression of IL-17 signaling associated genes[ 120 , 121 ]. A phase 2a clinical trial, sponsored by Idera Pharmaceuticals, involving use of IMO-8400 for the treatment of plaque psoriasis exhibited reduced psoriasis severity with good tolerance in the recruited subjects (NCT01899729)[ 122 ].…”
Section: Targeting Nucleic Acid Sensing Pathways: Therapeutic Strategiesmentioning
confidence: 99%
“…A compreensão da fisiopatologia da psoríase não está totalmente elucidada, mas há uma evolução disfuncional no local dos queratinócitos, onde ocorre uma doença sistêmica com desregulação imunológica associada à liberação de mediadores próinflamatórios. As causas patogênicas subjacentes estão relacionadas principalmente a hiperproliferação de queratinócitos, caracterizada por aumento de DNA síntese, uma redução de 10 vezes no comprimento do ciclo celular e, acredita-se que seja devido à hiperatividade de fatores de crescimento (CLINE et al, 2018;FEREIG et al, 2020).…”
Section: Introductionunclassified
“…Somando a isso, a angiogênese causa o alargamento dos espaços intercelulares e a dilatação dos capilares sanguíneos levando à produção de citocinas pró-inflamatórias, gerando assim a inflamação. Acredita-se que dessa maneira se ativem as células T, certamente por um antígeno desconhecido, que causa uma resposta imune, memorizada então pelas células de memória (CLINE et al, 2018;FEREIG et al, 2020).…”
Section: Introductionunclassified